Riskpilot← Back to searchSign inGet full accessCeriXClinic Hellerup No1 ApS
APSActiveCVR 40085114Strandvejen 191, st. 1Hospital activities · NACE 8610Est. 201813 employees
Revenue 2024
DKK 5,8M
+13% vs 2023
EBITDA margin
-88.9%
+15% vs 2023
Equity ratio
-521.6%
Financial strength
Net profit 2024
DKK -7,6M
-33% vs 2023
| Revenue | DKK 5,8M | +13% |
| EBITDA | DKK -5,2M | +15% |
| Net profit | DKK -7,6M | -33% |
| Total assets | DKK 4,1M | -39% |
| Equity | DKK -21,4M | -7% |
| Employees | 13 | — |
Legal name
CeriXClinic Hellerup No1 ApS
CVR number
40085114
Legal form
Anpartsselskab
NACE code
8610 · Hospital activities
Founded
12. december 2018
Share capital
DKK 51.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør og en direktør i forening.
Company purpose
Selskabets formål er drift af kosmetisk speciallægeklinik og dertilhørende virksomhed.
Address
Strandvejen 191, st. 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6.878 | 6.921 | 5.516 | 5.163 | 5.828 |
| Staff expenses | -10.131 | -10.888 | -11.500 | -10.954 | -8.581 |
| EBITDA | -3.253 | -3.967 | -5.985 | -6.077 | -5.181 |
| Depreciation & amort. | -6 | -6 | -6 | -6 | -3 |
| EBIT | -3.259 | -3.973 | -5.991 | -6.083 | -5.183 |
| Net financials | -366 | -154 | -299 | -1.133 | -1.772 |
| Profit before tax | -3.625 | -4.127 | -6.290 | -7.216 | -6.955 |
| Tax | -793 | -902 | -1.374 | -1.538 | 615 |
| Net profit | -2.832 | -3.225 | -4.915 | -5.678 | -7.570 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.982 | 3.916 | 4.674 | 6.756 | 4.110 |
| Equity | -6.013 | -9.237 | -14.325 | -20.003 | -21.436 |
| Long-term debt | 114 | 336 | 393 | 125 | 128 |
| Short-term debt | 8.880 | 12.817 | 18.606 | 26.635 | 24.417 |
| Total debt | 8.995 | 13.153 | 18.999 | 26.759 | 24.545 |
EBITDA margin
-88.9%
This company
15.8%
Market median
-663% vs market
20202024
Equity ratio
-521.6%
This company
38.2%
Market median
-1465% vs market
20202024
Return on equity
-757041700.0%
This company
18.4%
Market median
-4114357165% vs market
20202024
Net profit margin
-129.9%
This company
8.1%
Market median
-1704% vs market
20202024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KW Management | Management | 2019 |
RN Management | Management | 2018 |
PB Chief Executive Officer | Chief Executive Officer | 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rie Holding ApS
CeriXClinic Hellerup No1 ApS Board members of CeriXClinic Hellerup No1 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjenneth Wilhelm Leclaire-Rosenblum | Management | 0 companies |
| Riemaree Nataschia Leclaire-Rosenblum | Management | 0 companies |
| Peter Brøgger Andreasen | Chief Executive Officer | 0 companies |